Dr. Francisco M Beauchamp, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4500 Sunny Isle, Sunny Isle Shopping Center, Christiansted, VI 00820 Phone: 340-778-1994 Fax: 340-778-1994 |
Dr. Moise Mamouzette, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 201-202 Estate Ruby, Christiansted, VI 00820 Phone: 340-692-6263 Fax: 340-778-4922 |
Marc A Jerome, MD Obstetrics & Gynecology - Gynecology Medicare: Medicare Enrolled Practice Location: 184 Ruby Plaza, Christiansted, VI 00820 Phone: 340-778-5777 Fax: 340-778-3161 |
Ronald L Anders, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4007 Diamond Ruby, Christiansted, VI 00820 Phone: 340-778-6311 |
News Archive
Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same rate regardless of race, according to researchers at The University of Texas M. D. Anderson Cancer Center.
The Huffington Post Investigative Fund: "In the past two years, the agency has received reports of six patient deaths and several dozen injuries linked to malfunctions in the systems, Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, said in testimony prepared for a government hearing on Thursday. ... The FDA has been studying the issue for several years. Its latest concerns are surfacing as the government ramps up an ambitious plan to spend as much as $27 billion in stimulus money helping doctors and hospitals across the country purchase electronic medical records systems that rely on digital software rather than paper medical charts."
Inhibiting fatty acid synthesis in brain cancer cells may offer a new option to treat about 50 percent of deadly glioblastomas that are driven by amplified signaling of the epidermal growth factor receptor (EGFR), according to a first-of-its-kind study by researchers at UCLA's Jonsson Comprehensive Cancer Center.
Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has announced details of its upcoming workshop at the European Cytogenetics Conference 2011, held in Porto, Portugal (2–5 July).
› Verified 2 days ago